Subscribe
Vladimka production / Shutterstock
8 August 2025NewsAmericasMarisa Woutersen

$740M deal ends COVID-19 vaccine feud between CureVac and BioNTech

Payout and licensing deal grant US rights to COVID-19 and flu products | Agreement paves way for BioNTech’s $1.25 billion acquisition of CureVac.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
GSK: Pfizer, BioNTech ‘reaped billions of dollars’ from stealing COVID-19 patents
26 April 2024   New claim from GlaxoSmithKline is latest in litany of lawsuits against rivals | US lawsuit, potentially worth “billions of dollars”, is filed as UK trial kicks off between Moderna, Pfizer and BioNTech.
Big Pharma
BioNTech wins latest round in Covid-19 patent clash
21 December 2023   CureVac suffers a blow following a favourable earlier opinion delivered by the German Federal Patent Court | Decision invalidates a patent related to mRNA tech.
Big Pharma
CureVac sues BioNTech over mRNA technology
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.


Editor's picks

BMS blocks biosimilar version of blockbuster cancer drug in India
Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025

Editor's picks

Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025
Africa
Explainer: ARIPO’s role in Plant Variety Protection
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

More on this story

Americas
GSK: Pfizer, BioNTech ‘reaped billions of dollars’ from stealing COVID-19 patents
26 April 2024   New claim from GlaxoSmithKline is latest in litany of lawsuits against rivals | US lawsuit, potentially worth “billions of dollars”, is filed as UK trial kicks off between Moderna, Pfizer and BioNTech.
Big Pharma
BioNTech wins latest round in Covid-19 patent clash
21 December 2023   CureVac suffers a blow following a favourable earlier opinion delivered by the German Federal Patent Court | Decision invalidates a patent related to mRNA tech.
Big Pharma
CureVac sues BioNTech over mRNA technology
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.

More on this story

Americas
GSK: Pfizer, BioNTech ‘reaped billions of dollars’ from stealing COVID-19 patents
26 April 2024   New claim from GlaxoSmithKline is latest in litany of lawsuits against rivals | US lawsuit, potentially worth “billions of dollars”, is filed as UK trial kicks off between Moderna, Pfizer and BioNTech.
Big Pharma
BioNTech wins latest round in Covid-19 patent clash
21 December 2023   CureVac suffers a blow following a favourable earlier opinion delivered by the German Federal Patent Court | Decision invalidates a patent related to mRNA tech.
Big Pharma
CureVac sues BioNTech over mRNA technology
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.

More features

CyDex trade secrets case tossed by Italian court in rare ruling
Chemical reaction: Why AI drug discovery demands a new IP plan
EIP strengthens UPC offering with new hire
European Patent Office’s G1/25 referral under the microscope
Pfizer loses UK appeal over Moderna Covid-19 vaccine patent
WATCH: UPC update—shaping patent litigation
Bayer’s Xarelto patent struck down by German court
Teva draws line under asthma inhaler feud with US rival